Study of Lipid Profiles Levels and Some Parameters of Glucose Monitoring As Predictive Indicators of Recurrent MI in Patients Undergoing Elective Percutaneous Coronary Intervention (PCI)
DOI:
https://doi.org/10.36329/jkcm/2022/v2.i9.13287Keywords:
Insulin, HAMA-IR & Lipid profile., Glucose, CVDAbstract
Coronary heart disease (CHD) also known as coronary artery disease (CAD) or ischemic heart disease (IHD), where it is caused by hindrance of blood transit to muscle of heart cause to collect the lipid and cholesterol on the inner wall of the heart. Because of atherosclerosis, CAD contains many types of disease: stable angina, unstable angina, myocardial infarction (MI), and sudden cardiac death. Percutaneous Coronary Intervention (PCI) is known as angioplasty is a non-surgical operation performed using a catheter to cram either inflate a balloon in the narrowing place or a stent (a very small fin grid tube made of either plastic or metal of stainless steel).
Downloads
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Rasha Hasan Jasim, Ahssan Ali Lefta
This work is licensed under a Creative Commons Attribution 4.0 International License.
which allows users to copy, create extracts, abstracts, and new works from the Article, alter and revise the Article, and make commercial use of the Article (including reuse and/or resale of the Article by commercial entities), provided the user gives appropriate credit (with a link to the formal publication through the relevant DOI), provides a link to the license, indicates if changes were made and the licensor is not represented as endorsing the use made of the work.
How to Cite
